Extended release formulation of a new IOP lowering drug for improved treatment of glaucoma
Ended Project Grant Awarded Last action
- Award ID
- R43EY029909
- Recipient
-
Tavo Biotherapeutics, Inc. UEI F6W7H78TK9B1
- Awarding agency
-
National Eye Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $280,000
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date
- Originally
- Place of performance
- Memphis, TN 38120, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $55,000 | |
| Original award | $225,000 |
Quick answers
Who received award R43EY029909?
R43EY029909 was awarded to Tavo Biotherapeutics, Inc. by National Eye Institute (National Institutes of Health) on June 1, 2019.
How much is award R43EY029909 worth?
$280,000 has been obligated on R43EY029909.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award